Gastrointestinal fistula
Methodology & AI Transparency ⓘ
Gastrointestinal fistula Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Under Acid Reflux, GERD & Upper GI Health diagnostic criteria (K31.6), workup for Gastrointestinal fistula integrates ambulatory pH-impedance monitoring in Gastrointestinal fistula (K31.6: when refractory) with evidence-graded therapy tailored to Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) response.
- 2 Real-world patient consensus: Federal ICD-10-CM code K31.6 categorizes Gastrointestinal fistula under Acid Reflux, GERD & Upper GI Health.
- 3 Typical cash cost range: Primary evaluation for Gastrointestinal fistula incorporates ambulatory pH-impedance monitoring in Gastrointestinal fistula (K31.6: when refractory) and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Gastrointestinal fistula: Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) (B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K31.6)) and H. pylori Stool in Gastrointestinal fistula (K31.6: Antigen or Urea).
Ask our AI Specialists anything about Gastrointestinal fistula
What Is Gastrointestinal fistula?
Under Acid Reflux, GERD & Upper GI Health diagnostic criteria (K31.6), workup for Gastrointestinal fistula integrates ambulatory pH-impedance monitoring in Gastrointestinal fistula (K31.6: when refractory) with evidence-graded therapy tailored to Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) response.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in gerd & stomach, Gastrointestinal fistula (K31.6) involves gastric acid/pepsin mucosal in Gastrointestinal fistula (K31.6: backwash). progression correlates with shifts in Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) (B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K31.6)).
Common Symptoms & Clinical Signs
- • Presentation of Gastrointestinal fistula (K31.6): post-meal retrosternal heartburn in Gastrointestinal fistula (K31.6: or sour acid)
- • Secondary Gastrointestinal fistula clinical sign: epigastric burning, early in Gastrointestinal fistula (K31.6: satiety, or upper-abdominal)
- • Symptom flares in Gastrointestinal fistula correlating with Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) deviation outside B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K31.6)
- • Functional gerd & stomach impact requiring ambulatory pH-impedance monitoring in Gastrointestinal fistula (K31.6: when refractory) evaluation (K31.6)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Gastrointestinal fistula Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K31.6 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Gastrointestinal fistula (K31.6: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K31.6) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: H. pylori Stool in Gastrointestinal fistula (K31.6: Antigen or Urea) | Negative (K31.6) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Gastrointestinal fistula (K31.6: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K31.6) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Gastrointestinal fistula
Treatment selection for Gastrointestinal fistula depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Gastrointestinal fistula)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| What the Latest Evidence Really Says About Gastrointestinal side effects of metformin treatment in patients with type 2 The risk of gastrointestinal side effects such as abdominal pain, nausea and diarrhea is higher in type 2 diabetes patients treated with metformin compared to other antidiabetic drugs. Frontiers in endocrinology • 2022-01-15 • Meta-Analysis | Multi-cohort | 92/100 | PMID 36187122 ↗ |
| What the Latest Evidence Really Says About Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese Compared to placebo, both Semaglutide and tirzepatide are associated with increased GI adverse outcomes, with most cases being mild. Annals of Saudi medicine • 2025-01-15 • Meta-Analysis | Multi-cohort | 92/100 | PMID 40189856 ↗ |
| Can This Approach Help? Inside the Latest Research on Gastrointestinal tolerability and weight reduction associated with tirzepatide in In this post hoc analysis, GI AEs appeared to contribute slightly to the weight reduction seen with tirzepatide in participants with obesity or overweight with or without T2D. Diabetes, obesity & metabolism • 2025-04-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39789843 ↗ |
| Can This Approach Help? Inside the Latest Research on Dupilumab Improves Endoscopic Features in Adult and Adolescent Patients with At W24, patients showed greater improvement with dupilumab vs placebo in EREFS WOR total score (least squares mean difference [95% confidence interval] -2.17 [-2.59, -1.75], inflammatory subscore -1.65 [-1.96, -1.35], and... Clinical and translational gastroenterology • 2026-10-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 42658181 ↗ |
| Can This Approach Help? Inside the Latest Research on Impact of an oral purified microbiome therapeutic on the gastrointestinal These findings on the pharmacology of VOS underscore the importance of rapidly restoring key protective functions of the microbiome in patients with recurrent CDI to achieve durable prevention of recurrence, as observed in the... Nature medicine • 2026-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41491103 ↗ |
Gastrointestinal fistula Patient Community & “People Like Me” Threads
Filter Gastrointestinal fistula community threads and patient logs by age, biological sex, dosage, and treatment duration.